Age: 66.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (COVID-19) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Patient not had any drug allergy.  Concurrent medical conditions included Blood pressure high.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 19-May-2022 to 23-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: negative Negative on the 4th day. In June 2022, SARS-CoV-2 test: positive Positive. On an unknown date, SARS-CoV-2 test: positive Positive for antigen..     For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. It was reported that the patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. It was reported that patient had mild scratchy throat congestion and tested positive for antigen. Patient started Paxlovid very early. Symptoms improved on 3 days, tested negative on 4th day. Patient finished the Paxlovid and on 4-JUN-2022 started getting same symptoms 3 days after testing negative and tested positive again.  Company comment-This spontaneous case concerns an elderly patient aged 66 years of unknown gender, with no relevant medical history reported, who experienced the unexpected non serious of Covid 19 on an unknown date after receiving the 2nd dose of mRNA-1273 vaccine in the covid 19 vaccination series. Patient reported covid symptoms, tested positive for antigen on an unknown date and was treated with Paxlovid from 19th May 2022 to 23rd May2022 for 5 days. Symptoms improved after 3 days with a negative test on 4th day. Three days later was tested positive again with recurrence of symptoms. The current pandemic situation of COVID 19 may remain as confounder. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed per medical judgement.; Sender's Comments: This spontaneous case concerns an elderly patient aged 66 years of unknown gender, with no relevant medical history reported, who experienced the unexpected non serious of Covid 19 on an unknown date after receiving the 2nd dose of mRNA-1273 vaccine in the covid 19 vaccination series. Patient reported covid symptoms, tested positive for antigen on an unknown date and was treated with Paxlovid from 19th May 2022 to 23rd May2022 for 5 days. Symptoms improved after 3 days with a negative test on 4th day. Three days later was tested positive again with recurrence of symptoms. The current pandemic situation of COVID 19 may remain as confounder. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed per medical judgement.